test-bank-for-pharmacotherapeutics-for-advanced-practice-nurse-prescribers-4th-edition-woo-robinson-isbn-no-10-7-isbn-no-13-978-0complete-guide-achapter-1-55.pdf

TEST BANK
|

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
| | | | | |


edition Woo Robinson Test Bank
| | | | |




Chapter |1. |The |Role |of |the |Nurse |Practitioner |as |PrescriberMultiple |Choice

Identify |the |choice |that |best |completes |the |statement |or |answers |the |question.

1. |Nurse |practitioner |prescriptive |authority |is |regulated | by:
1. The |National |Council |of |State |Boards |of |Nursing
2. The |U.S. |Drug |Enforcement |Administration
3. The |State |Board |of |Nursing |for |each |state
4. The |State |Board |of |Pharmacy

2. |The |benefits |to |the |patient |of |having |an |Advanced |Practice |Registered |Nurse |(APRN) |prescriber
|include:

1. Nurses |know |more |about |Pharmacology|than |other |prescribers |because |they |take |it
|both |in |their |basic |nursing |program |and |in |their |APRN |program.

2. Nurses |care |for |the |patient |from |a |holistic |approach |and |include |the |patient |in
|decision |making |regarding |their |care.
3. APRNs |are |less |likely|to |prescribe |narcotics |and |other |controlled |substances.
4. APRNs |are |able |to |prescribe |independently |in |all |states, |whereas |a |physician’s
|assistant |needs |to |have |a |physician |supervising |their |practice.


3. |Clinical |judgment |in |prescribing |includes:
1. Factoring |in |the |cost |to |the |patient |of |the |medication |prescribed
2. Always |prescribing |the |newest |medication |available |for |the |disease |process
3. Handing |out |drug |samples |to |poor |patients
4. Prescribing |all |generic |medications |to |cut |costs
4. |Criteria |for |choosing |an |effective |drug |for |a |disorder | include:
1. Asking |the |patient |what |drug |they |think |would |work |best |for |them
2. Consulting |nationally |recognized |guidelines |for |disease |management
3. Prescribing |medications |that |are |available |as |samples |before |writing |a |prescription
4. Following |U.S. |Drug |Enforcement |Administration |guidelines |for |prescribing
5. |Nurse |practitioner |practice |may |thrive |under |health-care |reform |because |of:
1. The |demonstrated |ability |of |nurse |practitioners |to |control |costs |and |improve |patient
|outcomes

2. The |fact |that |nurse |practitioners |will |be |able |to |practice |independently
3. The |fact |that |nurse |practitioners |will |have |full |reimbursement |under |health-
|care |reform

4. The |ability |to |shift |accountability |for |Medicaid |to |the |state |level

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
| | | | | |


edition Woo Robinson Test Bank
| | | | |




Chapter |1. |The |Role |of |the |Nurse |Practitioner |as |Prescriber
|Answer |Section



MULTIPLE |CHOICE

1. ANS: | |3 PTS: | 1
2. ANS: | |2 PTS: | 1
3. ANS: | |1 PTS: | 1

4. ANS: | |2 PTS: | 1

5. ANS: | |1 PTS: | 1

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
| | | | | |


edition Woo Robinson Test Bank
| | | | |




Chapter |2. |Review |of |the |Basic |Principles |of |Pharmacology

|Multiple |Choice
Identify |the |choice |that |best |completes |the |statement |or |answers |the |question.


1. |A |patient’s |nutritional |intake |and |laboratory |results |reflect |hypoalbuminemia. |This |is |critical |to
|prescribing |because:

1. Distribution |of |drugs |to |target |tissue |may |be |affected.
2. The |solubility |of |the |drug |will |not |match |the |site |of |absorption.
3. There |will |be |less |free |drug |available |to |generate |an |effect.
4. Drugs |bound |to |albumin |are |readily |excreted |by |the |kidneys.
2. |Drugs |that |have |a |significant |first-pass | effect:
1. Must |be |given |by |the |enteral |(oral) |route |only
2. Bypass |the |hepatic |circulation
3. Are |rapidly |metabolized |by |the |liver |and |may |have |little |if |any |desired |action
4. Are |converted |by |the |liver |to |more |active |and |fat-soluble |forms
3. |The |route |of |excretion |of |a |volatile |drug |will |likely |be | the:
|

1. Kidneys
2. Lungs
3. Bile |and |feces
4. Skin

4. |Medroxyprogesterone |(Depo |Provera) |is |prescribed |intramuscularly |(IM) |to |create |a |storage
|reservoir |of |the |drug. |Storage |reservoirs:

1. Assure |that |the |drug |will |reach |its |intended |target |tissue
2. Are |the |reason |for |giving |loading |doses
3. Increase |the |length |of |time |a |drug |is |available |and |active
4. Are |most |common |in |collagen |tissues
5. |The |NP |chooses |to |give |cephalexin |every |8 |hours |based |on |knowledge |of |the |drug’s:
1. Propensity|to |go |to |the |target |receptor
2. Biological |half-life
3. Pharmacodynamics
4. Safety |and |side |effects

6. |Azithromycin |dosing |requires |that |the |first |day’s |dosage |be |twice |those |of |the |other |4 |days |of |the
|prescription. |This |is |considered |a |loading |dose. |A |loading |dose:

1. Rapidly|achieves |drug |levels |in |the |therapeutic |range
2. Requires |four- |to |five-half-lives |to |attain
3. Is |influenced |by|renal |function
4. Is |directly |related |to |the |drug |circulating |to |the |target |tissues

7. |The |point |in |time |on |the |drug |concentration |curve |that |indicates |the |first |sign |of |a |therapeutic |effect |is
|the:

1. Minimum |adverse |effect |level
2. Peak |of |action